A Clinical Study to evaluate the effectiveness of Safoof-e-Deedan in worm infestation.

A Clinical Study of Deedan-e-Ama (Intestinal Worms) to Assess the Effectiveness of Safoof-e-Deedan - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070624

Enrollment

Registered

2024-07-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K638- Other specified diseases of intestine

Interventions

Intervention1: Safoof-e-deedan: Artemisia absinthium (200gm) Embelia ribes (200gm) Ipomea trupthum (200gm) Rosa damascene (200gm) Ptychotis ajowan DC (10gm) Make fine powder and given orally 2-4gm wit

Eligibility

Inclusion criteria

Inclusion criteria: Patients having history of abdominal pain, decrease appetite, weight loss etc. Willing to participate in the study and follows instructions.

Exclusion criteria

Exclusion criteria: Patients below 5 years and above 14 years. Patients who fail to follow up. Known case of any systemic disease i.e.- RHD, Nephrotic Syndrome, Bronchial Asthma, Diabetes,TB, Liver and Blood born disease etc.

Design outcomes

Primary

Measure	Time frame
Changes in subjective parameters such as abdominal pain,abdominal distension,decrease appetite,weight loss etc.Timepoint: 10 days	—

Secondary

Measure	Time frame
Changes in objective parameters like ova/cyst in Stool and Hb%, DLC and ESR in BloodTimepoint: 10 days	—

Countries

India

Contacts

Public ContactDr Md Sohail

State Unani Medical College and Hospital

Shlt869@gmail.com8279944096

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026